Boswellia is a purified frankincense-tree resin whose natural acids calm inflammation. Its strongest use is easing knee-arthritis pain and stiffness, usually after about a month of steady use. Weaker evidence suggests help for blood sugar, cholesterol, and exercise recovery. It is low-cost and generally well tolerated, with mainly mild stomach complaints; product quality varies widely. (Full Review)

Protocol

Standard Dose

100–250 mg once daily

high-AKBA (~20–30%) standardized extract; or 300–400 mg of ~65% boswellic-acid extract two to three times daily

Timing

With a fatty meal

improves absorption and reduces stomach upset; align with the largest fat-containing meal

Form

Standardized extract

standardized to boswellic acids/AKBA; branded 5-Loxin, Aflapin, AprèsFlex most studied

Time to effect

Joint pain relief

~4 weeks

some improvement within 1–2 weeks; not an acute analgesic

Stiffness & function

~4 weeks

improved mobility with continuous use

Exercise recovery

~10 days

reduced soreness and faster strength recovery after intense exercise

Benefits

High: Knee osteoarthritis pain relief; knee osteoarthritis stiffness and physical function

Medium: Glycemic control and lipid profile in type 2 diabetes

Low: Reduced systemic inflammatory markers; ulcerative colitis and inflammatory bowel disease remission; asthma symptom control; exercise-induced muscle soreness and recovery; peritumoral brain edema reduction

Speculative: Anti-cancer activity; cognitive and neuroprotective effects

Contraindications

Pregnancy and breastfeeding

Known allergy to boswellia or related resins

Active peptic ulcer or recent upper-gastrointestinal hemorrhage

Key Interactions

CYP-metabolized drugs (some statins, calcium-channel blockers, cyclosporine, tacrolimus, warfarin)

NSAIDs (ibuprofen, naproxen)

Anti-inflammatory botanicals (curcumin, ginger, willow bark)

Blood-sugar/anti-inflammatory supplements (berberine, alpha-lipoic acid, omega-3)

Corticosteroids (radiotherapy setting)

Risk & Side Effects

High: Gastrointestinal discomfort

Medium: Allergic and dermatological reactions

Low: Reproductive and pregnancy concerns

Speculative: Drug-metabolism interactions; hepatic effects

Monitoring

Marker	Target	Why
hs-CRP	< 1.0 mg/L	Tracks systemic inflammation, the main target
HbA1c	< 5.4%	Gauges average blood sugar for metabolic goals
Fasting glucose	75–90 mg/dL	Complements HbA1c for blood-sugar response
ALT / AST	ALT < 25 U/L; AST < 25 U/L (approx.)	Safety check for the speculative liver concern
Lipid panel (LDL, triglycerides)	LDL context-dependent; triglycerides < 80 mg/dL	Assesses the metabolic/lipid benefit

Cadence: Joint symptoms at ~4 weeks and 8–12 weeks; metabolic and safety markers at ~3 months, then every 6–12 months

Qualitative Assessment

Joint pain intensity during activity and at rest
Morning joint stiffness duration
Physical function and mobility in daily tasks
Exercise recovery and post-exertion soreness
General energy and sense of well-being

Boswellia Extract for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment